Gastroesophageal Reflux Disease: A Review Of Symptomatic Management

Keywords

Chronic illness; Management options; Pharmacological advancements; Surgical advancements

Abstract

Considered as a chronic illness, gastroesophageal reflux disease (GERD) has manifested itself as a widespread condition throughout the adult population. As a growing epidemic, GERD has reached a staggering prevalence of 10% to 20% in the Western world, by affecting up to 30 million people in the United States alone. 1 Sixty percent of individuals in an adult population will experience symptoms and the impact of GERD over a period of 12 months, whereas a remarkable 20% to 30% of individuals will have weekly symptoms. 2 This rapid increase in the prevalence of the disease requires equally rapid management techniques. Although the disease itself has no cure, management of symptoms and certain pharmacological and surgical advancements have allowed for individuals affected by GERD to receive specific treatment options sufficient for them to live a healthy life. In this paper, such management options will be examined and discussed in reference to their effectiveness in treating the symptoms presented in GERD patients.

Publication Date

1-1-2018

Publication Title

Critical Reviews in Eukaryotic Gene Expression

Volume

28

Issue

1

Number of Pages

87-92

Document Type

Article

Personal Identifier

scopus

DOI Link

https://doi.org/10.1615/CritRevEukaryotGeneExpr.2018022767

Socpus ID

85047477241 (Scopus)

Source API URL

https://api.elsevier.com/content/abstract/scopus_id/85047477241

This document is currently not available here.

Share

COinS